HTG Molecular Diagnostics, Inc. (HTGMQ)

HTG Molecular Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0	12.21	9.6	22.4	7.62	8.43
Short-Term Investments	0	0	12.34	6.3	25.41	22.68
Cash & Cash Equivalents	0	12.21	21.94	28.7	33.03	31.11
Cash Growth	-	-44.35%	-23.53%	-13.12%	6.16%	212.12%
Receivables	0	1.42	2.09	1.59	3.16	5.01
Inventory	0	0.91	1.99	1.49	1.27	1.31
Other Current Assets	0	1.11	1.16	1.09	3.9	0.57
Total Current Assets	0	15.65	27.19	32.87	41.37	38
Property, Plant & Equipment	0	1.61	2.46	2.24	3.45	2.37
Other Long-Term Assets	0	0.52	0.81	0.09	0.3	3.4
Total Long-Term Assets	0	2.13	3.27	2.33	3.75	5.77
Total Assets	0	17.78	30.46	35.2	45.12	43.77
Accounts Payable	0	1.16	1.65	1.35	1.66	1.85
Deferred Revenue	0	2.21	0.12	0.19	0.43	0.33
Current Debt	0	4.29	5.58	3.71	3.75	3.36
Other Current Liabilities	0	0.62	2.59	2	3.06	1.48
Total Current Liabilities	0	8.27	9.94	7.24	8.9	7.02
Long-Term Debt	0	0.55	6.13	8.94	7.51	9.68
Other Long-Term Liabilities	0	3.57	3.99	4.54	4.74	5.98
Total Long-Term Liabilities	0	4.12	10.12	13.48	12.25	15.66
Total Liabilities	0	12.39	20.06	20.71	21.15	22.68
Total Debt	0	4.83	11.71	12.64	11.25	9.68
Debt Growth	-	-58.72%	-7.39%	12.35%	16.28%	10.56%
Common Stock	0	0	0.01	0.01	0.06	0.03
Retained Earnings	0	-229.93	-208.33	-191.19	-170.32	-151.02
Comprehensive Income	0	0	0	0.01	-0	-0
Shareholders' Equity	0	5.39	10.4	14.48	23.97	21.09
Total Liabilities and Equity	0	17.78	30.46	35.2	45.12	43.77
Net Cash / Debt	0	7.38	10.23	16.05	21.78	21.43
Net Cash / Debt Growth	-	-27.92%	-36.24%	-26.29%	1.59%	1665.28%
Net Cash Per Share	-	8.30	17.71	41.62	102.88	140.18
Working Capital	0	7.38	17.24	25.63	32.47	30.98
Book Value Per Share	-	6.06	17.99	37.56	113.24	137.94

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.